N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide

C122H114N16O11 — CID 159194260

IUPACN-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide
SMILESCOC1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc5ccccc5c4)c3c2)CC1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1ccc(CO)cc1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1.O=C1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc(OCc5ccccc5)cc4)c3c2)C1
InChIInChI=1S/C26H23N3O3.C25H25N3O2.C25H19N3O2.C25H27N3O2.C21H20N4O2/c30-21-10-6-19(14-21)26(31)27-20-9-13-24-23(15-20)25(29-28-24)18-7-11-22(12-8-18)32-16-17-4-2-1-3-5-17;1-30-21-11-8-17(9-12-21)25(29)26-20-10-13-23-22(15-20)24(28-27-23)19-7-6-16-4-2-3-5-18(16)14-19;29-15-16-5-7-18(8-6-16)25(30)26-21-11-12-23-22(14-21)24(28-27-23)20-10-9-17-3-1-2-4-19(17)13-20;29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13/h1-5,7-9,11-13,15,19H,6,10,14,16H2,(H,27,31)(H,28,29);2-7,10,13-15,17,21H,8-9,11-12H2,1H3,(H,26,29)(H,27,28);1-14,29H,15H2,(H,26,30)(H,27,28);5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25)
InChIKeyKOLRNXLUXAKSIC-UHFFFAOYSA-N
MW1980.35 g/mol
LogP25.35
Rot. Bonds28

About N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide

N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide (PubChem CID 159194260) has the molecular formula C122H114N16O11 and a molecular weight of 1980.35 g/mol. Its IUPAC name is N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide.

Molecular Properties

Compound NameN-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide
PubChem CID159194260
Molecular FormulaC122H114N16O11
Molecular Weight1980.35 g/mol
Exact Mass1978.89
IUPAC NameN-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide
SMILESCOC1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc5ccccc5c4)c3c2)CC1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1ccc(CO)cc1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1.O=C1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc(OCc5ccccc5)cc4)c3c2)C1
InChIInChI=1S/C26H23N3O3.C25H25N3O2.C25H19N3O2.C25H27N3O2.C21H20N4O2/c30-21-10-6-19(14-21)26(31)27-20-9-13-24-23(15-20)25(29-28-24)18-7-11-22(12-8-18)32-16-17-4-2-1-3-5-17;1-30-21-11-8-17(9-12-21)25(29)26-20-10-13-23-22(15-20)24(28-27-23)19-7-6-16-4-2-3-5-18(16)14-19;29-15-16-5-7-18(8-6-16)25(30)26-21-11-12-23-22(14-21)24(28-27-23)20-10-9-17-3-1-2-4-19(17)13-20;29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13/h1-5,7-9,11-13,15,19H,6,10,14,16H2,(H,27,31)(H,28,29);2-7,10,13-15,17,21H,8-9,11-12H2,1H3,(H,26,29)(H,27,28);1-14,29H,15H2,(H,26,30)(H,27,28);5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25)
InChIKeyKOLRNXLUXAKSIC-UHFFFAOYSA-N
XLogP25.35
TPSA393.99 Ų
H-Bond Donors13
H-Bond Acceptors16
Rotatable Bonds28
Heavy Atoms149
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001980.35
LogP ≤ 525.35
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[3-(4-tert-butylphenyl)-1H-indazol-5-yl]-1-phenylcyclopropane-1-carboxamide;4-(dimethylamino)-N-[3-[4-(trifluoromethoxy)phenyl]-1H-indazol-5-yl]benzamide;N-[3-(3-fluorophenyl)-1H-indazol-5-yl]-2-oxo-2-phenylacetamide;3-hydroxy-2,2-dimethyl-N-(3-naphthalen-2-yl-1H-indazol-5-yl)propanamide;3-hydroxy-3-methyl-N-[3-(4-phenoxyphenyl)-1H-indazol-5-yl]butanamide
CID 157935670
N-[3-(4-tert-butylphenyl)-1H-indazol-5-yl]-1-phenylcyclopropane-1-carboxamide;4-(dimethylamino)-N-[3-[4-(trifluoromethoxy)phenyl]-1H-indazol-5-yl]benzamide;N-[3-(3-fluoro-4-phenylphenyl)-1H-indazol-5-yl]-2-oxo-2-phenylacetamide;3-hydroxy-2,2-dimethyl-N-(3-naphthalen-2-yl-1H-indazol-5-yl)propanamide;3-hydroxy-3-methyl-N-[3-(4-phenoxyphenyl)-1H-indazol-5-yl]butanamide
CID 159569294
5-acetamido-N-phenyl-1H-indazole-3-carboxamide;5-(cyclopropanecarbonylamino)-N-phenyl-1H-indazole-3-carboxamide;5-(furan-2-carbonylamino)-N-phenyl-1H-indazole-3-carboxamide;5-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyl-1H-indazole-3-carboxamide;3-(phenylcarbamoyl)-1H-isoindole-5-carboxylic acid
CID 157227548
4-amino-N-[3-[4-(4-methoxyphenyl)phenyl]-1H-indazol-5-yl]-2-phenylbutanamide;4-amino-N-[3-(4-phenoxyphenyl)-1H-indazol-5-yl]-2-phenylbutanamide;2-[4-[5-[(4-amino-2-phenylbutanoyl)amino]-1H-indazol-3-yl]phenyl]acetic acid;3-[4-[5-[(4-amino-2-phenylbutanoyl)amino]-1H-indazol-3-yl]phenyl]propanoic acid
CID 157921313
N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-4-hydroxycyclohexane-1-carboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;4-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)-5-phenylpentanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide
CID 160049107
N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclopropanecarboxamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)thiophene-2-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide
CID 161020685

Frequently Asked Questions

What is the IUPAC name of N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide?
The IUPAC name of N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide (CID 159194260) is N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide.
What is the SMILES notation for N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide?
The canonical SMILES for N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide is COC1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc5ccccc5c4)c3c2)CC1.O=C(CCCCCCCO)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1)c1ccc(CO)cc1.O=C(Nc1cccc(-c2n[nH]c3ccc(NC(=O)C4CC4)cc23)c1)C1CC1.O=C1CCC(C(=O)Nc2ccc3[nH]nc(-c4ccc(OCc5ccccc5)cc4)c3c2)C1.
What is the InChIKey of N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide?
The InChIKey is KOLRNXLUXAKSIC-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23N3O3.C25H25N3O2.C25H19N3O2.C25H27N3O2.C21H20N4O2/c30-21-10-6-19(14-21)26(31)27-20-9-13-24-23(15-20)25(29-28-24)18-7-11-22(12-8-18)32-16-17-4-2-1-3-5-17;1-30-21-11-8-17(9-12-21)25(29)26-20-10-13-23-22(15-20)24(28-27-23)19-7-6-16-4-2-3-5-18(16)14-19;29-15-16-5-7-18(8-6-16)25(30)26-21-11-12-23-22(14-21)24(28-27-23)20-10-9-17-3-1-2-4-19(17)13-20;29-15-7-3-1-2-4-10-24(30)26-21-13-14-23-22(17-21)25(28-27-23)20-12-11-18-8-5-6-9-19(18)16-20;26-20(12-4-5-12)22-15-3-1-2-14(10-15)19-17-11-16(8-9-18(17)24-25-19)23-21(27)13-6-7-13/h1-5,7-9,11-13,15,19H,6,10,14,16H2,(H,27,31)(H,28,29);2-7,10,13-15,17,21H,8-9,11-12H2,1H3,(H,26,29)(H,27,28);1-14,29H,15H2,(H,26,30)(H,27,28);5-6,8-9,11-14,16-17,29H,1-4,7,10,15H2,(H,26,30)(H,27,28);1-3,8-13H,4-7H2,(H,22,26)(H,23,27)(H,24,25).
What are the key properties of N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide?
N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide has a molecular weight of 1980.35 g/mol, XLogP of 25.35, 28 rotatable bonds, 13 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[3-(cyclopropanecarbonylamino)phenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;8-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)octanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide;3-oxo-N-[3-(4-phenylmethoxyphenyl)-1H-indazol-5-yl]cyclopentane-1-carboxamide is sourced from PubChem (CID 159194260), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).